1nHealth is a digital technology company utilizing big data analysis to tap qualified and engaged subjects that others ignore. By analyzing consumer behaviors, instead of channel targeting, we bring subjects who match the inclusion criteria for the clinical study. Traditional clinical trial recruitment is an antiquated, under-delivering methodology. To the contrary, our bold, data-rich approach transforms the status-quo and encourages conversion until the last patient is in. We use a combination of digital best practices, industry relationships and proprietary algorithms to achieve a singular outcome: studies that are fully recruited on-time and on-budget. We target based on an individualâs habits and behaviors, not who they say they are on social media. This allows us to recruit subjects who are otherwise missed. We understand the parameters of geo-targeting. From basic demographics to refined details, we identify untouched subjects for your database. Founded by Dan Brenner in 2019, 1nHealth is backed by investors that include Dan Brenner and is headquartered in Orlando.